
Cholecystokinin
From Gallbladder to Cognition and Beyond
- 1st Edition - March 10, 2025
- Editors: Christine Feinle-Bisset, Jens F Rehfeld
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 3 7 2 0 - 1
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 3 7 2 1 - 8
Cholecystokinin: From Gallbladder to Cognition and Beyond covers the biology, physiology, and pathophysiological roles of cholecystokinin (CCK) peptides. The book begins with a… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteCholecystokinin: From Gallbladder to Cognition and Beyond covers the biology, physiology, and pathophysiological roles of cholecystokinin (CCK) peptides. The book begins with a historical overview before providing in-depth chapters on the biology of CCK, from biogenesis to cell expression, including intestinal and extraintestinal endocrine cells, the central and peripheral nervous system, and receptor function. CCK phylogenesis is explored across various species, including fish, birds, insects and amphibians. The physiology of CCK covers intestinal CCK secretion, the gallbladder and pancreas, and the role of CCK in the gut-brain axis, gastrointestinal motor function, appetite regulation, and cardiovascular function.
Methods used for CCK research are also discussed. A number of chapters then covers the roles of CCK in various diseases, including metabolic diseases, tumors, psychiatric illness, the immune system and nociception, as well as potential therapeutic approaches targeting CCK receptors.
Methods used for CCK research are also discussed. A number of chapters then covers the roles of CCK in various diseases, including metabolic diseases, tumors, psychiatric illness, the immune system and nociception, as well as potential therapeutic approaches targeting CCK receptors.
- Provides detailed overviews of the biology, including phylogenesis, biogenesis and distribution of expression, of cholecystokinin peptides and receptors
- Explores the physiology of CCK, its metabolic functions, and role in a range of medical conditions, including obesity, type 2 diabetes, tumors, nociception, and cerebral disease
- Considers the latest developments in CCK-based therapeutic approaches and future directions for CCK research
Biological and biomedical sciences researchers at PhD level and above. Research physicians in areas where CCK plays a key role in disease states
- Cholecystokinin
- Cover image
- Title page
- Table of Contents
- Front Matter
- Copyright
- Contributors
- Preface
- Series preface
- Part I: History
- Chapter 1 Milestones in the history of cholecystokinin
- Abstract
- Introduction
- Milestones
- Premonitions
- The physiological identification of CCK
- The structural identifications as CCK-33
- CCK and satiation signaling
- CCK expression in central and peripheral neurons
- ProCCK and its processing products
- CCK in “classic” endocrine cells, germ cells, immune cells, cardiac myocytes, and tumor cells
- Reliable plasma measurements
- The molecular receptor identification
- Concluding comments
- References
- Part II: Biology of cholecystokinin
- Chapter 2 Evolutionarily conserved roles of cholecystokinin signaling
- Abstract
- Introduction
- CCK signaling in mammals, a brief overview
- CCK signaling in nonmammalian vertebrates
- Elasmobranchs (cartilaginous fishes)
- Teleost fish
- Amphibians and reptiles
- Birds
- Skin-derived CCKs (caeruleins) in frogs
- CCK signaling in invertebrates
- CCK/SK peptides and their precursors in invertebrates
- CCK/SK receptors in invertebrates
- Distribution of CCK/SK peptides and receptors in invertebrates
- Functional roles of SK signaling in invertebrates
- Identified neurons and functional roles of CCK/SK signaling in Drosophila
- Nociception in Drosophila
- Aggression and courtship behavior in Drosophila
- SK, food attraction, feeding, and satiation in Drosophila
- CCK/SK signaling to regulate food intake differs mechanistically in invertebrates and mammals
- Conclusions and future perspectives
- References
- Chapter 3 The biogenesis and cell-specific expression of cholecystokinin peptides
- Abstract
- Acknowledgment
- Introduction
- The CCK gene, transcription, and translation
- PreproCCK
- ProCCK processing, general aspects
- ProCCK processing in gut endocrine cells
- ProCCK processing in central and peripheral neurons
- ProCCK processing in extraintestinal endocrine cells
- ProCCK processing in spermatogenic cells
- ProCCK processing in cardiac myocytes
- ProCCK processing in immune cells
- ProCCK processing in tumor cells
- Conclusion
- References
- Chapter 4 Cholecystokinin in intestinal and extraintestinal endocrine cells
- Abstract
- Introduction
- Receptors
- CCK in the intestine
- CCK secretion and GPCRs involved in I-cell signaling
- CCK in peripheral extraintestinal cells
- Extraintestinal endocrine cells
- CCK in the pancreas
- Spermatogenic cells
- Myocardial myocytes
- Kidney cells
- Conclusion
- References
- Chapter 5 Cholecystokinin in the central and peripheral nervous system
- Abstract
- Acknowledgments
- Introduction
- Methods to study the distribution of the CCK systems
- Anti-CCK antisera used in immunohistochemistry
- The in situ hybridization era
- CCK: A coexisting neuropeptide and features of peptide signaling
- CCK in the brain
- Ontogeny
- Overall distribution studies
- Cortex
- The hippocampal formation
- Other brain regions/nuclei
- CCK pathways
- CCK circuitries
- CCK-dopamine coexistence in neurons in the ventral mesencephalon
- CCK projections to striatum (caudate nucleus, caudatus putamen), nucleus accumbens, and olfactory tubercles
- CCK neuronal cell bodies in the medulla oblongata and spinal cord
- CCK in dorsal root ganglion neurons and their afferent projections
- CCK in the vagus system
- CCK in the gastrointestinal tract and associated ganglia
- Concluding remarks
- References
- Chapter 6 Cholecystokinin 1 and 2 receptors
- Abstract
- Acknowledgment
- Introduction
- Discovery of CCK receptors
- Characterization of CCK receptors
- Localization of CCK1R and CCK2R
- Signaling at CCK1R and CCK2R
- Physiologic effects of CCK1R activation
- Physiologic effects of CCK2R activation
- Drugs targeting CCK1R
- Drugs targeting CCK2R
- Conclusions
- References
- Chapter 7 The relationship between cholecystokinin and gastrin
- Abstract
- Introduction
- The common structure
- The evolutionary relationship
- The sulfation homology of cholecystokinins and gastrins
- The cell-specificity of CCK versus gastrin expression
- The cholecystokinin/gastrin receptors
- The secretory patterns of cholecystokinin and gastrin
- The specificity of assay measurements
- The distinction between gastrinomas and CCKomas
- CCK versus gastrin peptides as drug targets
- Conclusion
- References
- Part III: Physiology of cholecystokinin
- Chapter 8 Intestinal cholecystokinin secretion
- Abstract
- Introduction
- CCK peptide
- CCK-secreting I-cells—Location and anatomy
- CCK secretion
- A comment on CCK assays
- Nutrient stimulation
- Protein-mediated regulation of CCK secretion
- Regulation of CCK secretion by fat
- Carbohydrate-mediated regulation of intestinal CCK
- Neuronal connections
- CCK receptors
- Physiological functions of CCK
- Exocrine pancreas
- Gallbladder
- Gastric emptying
- Gastric secretion and growth
- Food intake
- Regulation of the endocrine pancreas
- CCK and other actions
- Future considerations
- References
- Chapter 9 Cholecystokinin and the gut-brain axis
- Abstract
- Introduction
- Gut-brain axis
- Sensory signaling from the gastrointestinal tract
- Gastric vagal afferents
- Small intestinal vagal afferents
- CCK signaling in vagal afferent neurons
- Plasticity
- Central inputs of vagal afferents
- Effects of CCK to modulate central vagal afferent transmission
- Effects of CCK to modulate NTS neuronal activity
- Effects of CCK to modulate DMV neuronal activity
- Modulation of central CCK responses
- CCK effects in pathophysiological conditions
- Conclusion
- References
- Chapter 10 CCK and the gallbladder
- Abstract
- Acknowledgment
- Introduction
- Cholecystokinin
- The gallbladder
- The sphincter of Oddi
- Assessment of gallbladder motor function
- Gallbladder motor function and CCK: Interdigestive and digestive states
- Interdigestive state
- Digestive state
- Effect of age and sex
- Pathophysiology: CCK secretion and gallbladder motility in various gastrointestinal conditions
- Upper gastrointestinal surgery
- Celiac disease
- Exocrine pancreas insufficiency
- Pancreatic surgery
- Colonic dysfunction and postcolectomy
- Total parenteral nutrition
- Total enteral nutrition
- Gallstone formation and gallstone disease
- Medication that affects CCK secretion
- Bile acid sequestrants
- Somatostatin and somatostatin analogs
- CCK receptor antagonists
- Conclusion
- References
- Chapter 11 Cholecystokinin and the exocrine pancreas
- Abstract
- Introduction
- Stimulation of pancreatic enzyme secretion by CCK (Fig. 1)
- Comparative aspects of CCK regulation of pancreatic secretion
- Fish
- Amphibians
- Reptiles
- Birds
- Other actions of CCK on the pancreas
- Stimulation of pancreatic growth by CCK
- Stimulation of pancreatic protein synthesis by CCK
- Stimulation or potentiation of pancreatic ductal secretion by CCK
- Regulation of acinar cell metabolism by CCK
- Actions of CCK on pancreatic acinar cells at the molecular level (Table 1)
- PLC—IP3—Ca2+ pathway
- DAG—PKC pathway
- mTOR pathway
- Other pathways activated by CCK
- Cholecystokinin and pancreatitis
- Conclusion
- References
- Chapter 12 Islet effects of cholecystokinin and exploitation in diabetes
- Abstract
- Introduction
- Diabetes and obesity
- Peptide therapeutics
- Cholecystokinin, tissue distribution, molecular forms, and analogs
- Key milestones in relation to CCK and pancreatic islets
- CCK stimulates insulin secretion in rodents
- CCK is essential for maintenance of islet function and survival
- CCK signaling pathways within islet beta-cells
- Impact of CCK on human islet function
- In vitro effects of CCK on human islets
- In vivo effects of CCK on human islets
- Combining CCK with other hormones for islet benefits
- CCK and GLP-1
- CCK and GIP
- CCK and peptides beyond incretins
- Safety concerns with CCK peptides
- Concluding remarks
- References
- Chapter 13 Cholecystokinin and gastrointestinal motor function
- Abstract
- Introduction
- GI motility patterns
- Fasting GI motility
- Postprandial GI motility
- Role of CCK in the regulation of GI motility
- Effects of CCK on esophageal motility
- Effects of CCK on gastric motility
- Effects of CCK on small intestinal motility
- Effects of CCK on colonic motility
- Roles of CCK in disordered GI motility and its therapeutic potential
- Achalasia and diffuse esophageal spasm
- Gastroesophageal reflux disease (GERD)
- Impaired gastric emptying
- Disorders of gut-brain interaction
- Constipation
- Conclusion
- References
- Chapter 14 Effect of cholecystokinin on food intake and appetite
- Abstract
- Introduction
- Impact of exogenous CCK on food intake
- Role of endogenous CCK on food intake
- Role of vagal gut-brain signaling in CCK action
- Interaction of CCK signaling with other metabolic signals
- Role of the enteric nervous system in CCK action on food intake
- Conclusion
- References
- Chapter 15 Cholecystokinin, nutrient preference, and taste aversion
- Abstract
- Acknowledgments
- Preamble
- Introduction
- On feeding, preference, and aversion
- CCK receptors
- The vagus: main mediator of intestinal CCK effects on feeding
- Modulation of CCK-8 effectiveness by nutritional status
- CCK signaling and nutrient preference
- CCK in the CNS
- CCK and bariatric surgery
- Conclusion
- References
- Chapter 16 Cholecystokinin in peripheral and central cardiovascular control
- Abstract
- Introduction
- Cholecystokinin and blood pressure
- Peripheral actions of CCK on the circulation
- Central and peripheral cardiorespiratory responses to CCK
- CCK and postprandial gastrointestinal hyperaemia
- Vagal afferent neurons and the actions of CCK on the circulation
- Cardiovascular responses to CCK in obesity
- Does endogenously released CCK modulate the vasomotor system?
- Conclusion
- References
- Chapter 17 Cholecystokinin in cardiac myocytes
- Abstract
- Introduction
- A notion of the endocrine cardiovascular system
- Early clues of cardiac cholecystokinin expression
- Identification of cardiac CCK peptide expression
- Cardiac localization of CCK peptide expression
- Endothelial CCK gene expression
- Lack of CCK or its receptor in relation to cardiovascular effects
- CCK and cardiovascular disease
- Distinguishing cardiac CCK from gut and brain CCK
- Conclusions
- References
- Part IV: Methods used for cholecystokinin research
- Chapter 18 Measurement of cholecystokinin in biological fluids
- Abstract
- Introduction
- Methodological principles for measurement of cholecystokinin
- The bioassay
- The radioimmunoassay (RIA)
- The enzyme-linked immunosorbent assay
- Mass-spectrometry approaches
- The processing-independent analysis
- The CCK radioimmunoassay
- Antibodies
- The tracer
- Additional RIA comments
- Molecular CCK pattern in tissue extracts, blood plasma, and cerebrospinal fluid
- Tissue extracts
- Plasma extracts
- The specific issue about CCK-58 in plasma
- Cerebrospinal fluid
- Concentration levels in plasma
- Levels of bioactive CCK in healthy subjects
- Levels of bioactive CCK in obesity
- Conclusion
- References
- Chapter 19 Cholecystokinin knockout mice: peripheral and central phenotypes
- Abstract
- Physiological function of cholecystokinin
- Generation of CCK knockout mice
- Evaluation of physiological functions of CCK using CCK-KO models
- Food intake in CCK-KO mice
- Digestion and absorption in CCK-KO mice
- Energy homeostasis in CCK-KO mice
- Glucoregulatory functions and leptin in CCK-KO mice
- Cognitive behaviors in CCK-KO mice
- Concluding remarks
- References
- Part V: Cholecystokinin in disease
- Chapter 20 Cholecystokinin in obesity and other disorders of eating
- Abstract
- Introduction
- CCK receptor subtypes
- CCK1 receptors and feeding regulation
- Metabolic consequences of the absence of CCK or CCK1 receptors
- Nutritional status modulates CCK effectiveness
- CCK in obesity
- CCK in eating disorders
- Anorexia nervosa
- Anorexia of aging
- Bulimia nervosa
- Binge eating disorder
- Conclusions
- References
- Chapter 21 Cholecystokinin in tumors
- Abstract
- Introduction
- Cholecystokinin expression in tumors
- CCKomas and the CCKoma syndrome
- Gastroenteropancreatic carcinomas
- Bronchial carcinomas
- Neuroendocrine tumors
- Pediatric tumors
- Cerebral tumors
- Cholecystokinin as a tumor growth factor
- Diagnostic methods for measurement of cholecystokinin from tumors
- Perspectives
- Conclusion
- References
- Chapter 22 Cholecystokinin and panic disorder
- Abstract
- Acknowledgments
- Introduction
- Investigating the effects of CCK in humans
- Confirming the panicogenic property of CCK-4
- Identifying neurotransmitter systems involved in the panicogenic effects of CCK-4
- Psychological mechanisms in the panicogenic effects of CCK-4
- The site of action of the panicogenic effects of CCK-4
- Effect of CCK2R agonists in other psychiatric disorders
- Genetic variants of the CCK system and panic disorder
- Animal research supporting the role of the CCK system in anxiety
- Evaluation of CCK receptor antagonists as antipanic agents
- Summary
- References
- Chapter 23 Cholecystokinin and the immune system
- Abstract
- Introduction
- CCK-releasing enteroendocrine cells as innate immune cells
- Indirect CCK immune modulation
- Immunoglobulin A
- Tight junctions
- Modulation of feeding by CCK during infection: An immunomodulatory axis
- Epithelial damage and the reserve stem cell niche
- CCK as a cytokine
- Innate immunity
- Professional antigen-presenting cells
- Adaptive immunity
- Conclusion
- References
- Chapter 24 Cholecystokinin in nociception and pain
- Abstract
- Introduction
- Nociception
- CCK signaling pathways
- Canonical CCK signaling pathways linked to nociception
- Downstream CCK Gαq signaling pathways linked to nociception
- Downstream CCK Gᵦᵧ signaling pathways linked to nociception
- Other signaling mechanisms
- Tools to study CCK signaling in nociception
- Rodent pain models
- Transgenic and reporter mice
- Otsuka Long Evans Tokushima fatty rat
- Drosophila CCK pathway
- Roles of CCK, CCK1R, and CCK2R in nociception and pain
- CCK
- CCK1R
- CCK2R
- CCK2R and opioid receptor interactions
- CCK in peripheral neuropathy
- Comorbidities associated with chronic pain
- CCK drug discovery and therapeutics for pain
- Pharmaceuticals to CCK1R
- Pharmaceuticals to CCK2R
- Conclusions
- References
- Part VI: Cholecystokinin-based novel therapeutic approaches
- Chapter 25 Potential therapeutics targeting cholecystokinin 1 receptors
- Abstract
- Acknowledgments
- Introduction
- Partial agonists/biased agonists
- Positive allosteric modulators
- Membrane cholesterol sensitivity of the CCK1 receptor
- Conclusions
- References
- Chapter 26 Reflections on cholecystokinin research: Past, present, and future
- Abstract
- A century of CCK research—And beyond
- Index
- No. of pages: 640
- Language: English
- Edition: 1
- Published: March 10, 2025
- Imprint: Academic Press
- Paperback ISBN: 9780443237201
- eBook ISBN: 9780443237218
CF
Christine Feinle-Bisset
Professor Christine Feinle-Bisset has a PhD in Nutrition and GI Physiology from the University of Stuttgart-Hohenheim, Germany. After gaining research experience at the University of Sheffield, UK and the University of Zurich, Switzerland, she joined the University of Adelaide in 2000, where she is currently a Professorial Research Fellow and a lead investigator in the Centre of Research Excellence in Translating Nutritional Science to Good Health. Her research is clinical and relates to the impact of nutrients on appetite, GI motor and hormone function and perception, in health, obesity and functional dyspepsia. Her work has contributed significantly to current concepts of the role of gastrointestinal mechanisms, including gut hormones and gastrointestinal motor activity, in the regulation of energy intake in health and obesity, and symptom generation in functional dyspepsia. She has published more than 220 publications, with over 15,000 citations.
Affiliations and expertise
Professorial Research Fellow, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, AustraliaJF
Jens F Rehfeld
Professor Jens F. Rehfeld has an MD from the University of Aarhus, and later DMSc and DSc in Clinical Biochemistry from the University of Copenhagen. He became professor in Medical Biochemistry at University of Aarhus in 1975, and of Clinical Biochemistry, University of Copenhagen, in 1981. He was also administrative head of the Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, until 2010.
His main research theme is bioactive peptides (in particular gastrin, cholecystokinin, and insulin), their biosynthesis, methods for measurement, and clinical relevance. He has published approximately 1100 publications, including 650 original articles, 90 review articles, 55 textbook chapters, and 8 books, and has more than 43,000 citations.
Affiliations and expertise
Professor, Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, DenmarkRead Cholecystokinin on ScienceDirect